Effect Of PRF Versus Xenograft In Closed Sinus Lift.

Implant or Graft; Rejection Clinical Trial

Official title:

Prf Controlled, Randamized Clinical Trial of THE EFFECT OF PLATELET RICH FIBRIN( PRF ) VERSUS XENOGRAFT IN CLOSED SINUS LIFT AND IMLANT PLACEMENT ON IMPLANT STABILITY IN PATIENTS WITH MISSING MAXILLARY PREMOLAR.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03684954
• Other study ID #: Cairo Univ.
• Status: Not yet recruiting
• Phase: N/A
• Start date: October 1, 2018
• Est. completion date: August 30, 2019

Study information

• Verified date: September 2018
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Indirect sinus lift with used PRF as a graft material versus xenograft

Description:

Crestal incision and reflect the tissue until exposure of the bone, then use drilling to make osteotomy. Then use sutable osteotomes to elevate the sinus floor, then pack of Prf or bone graft in the osteotomy and implant placement . Then closed the flap and suturing.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 10
• Est. completion date: August 30, 2019
• Est. primary completion date: August 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 25 Years to 45 Years

Eligibility

Inclusion Criteria:

• Edentulous area and bone high at least 5-6 mm below the maxillary sinus at maxillary premolar.

• Good oral hygiene.

Exclusion Criteria:

• bad oral hygiene.

• patient with systemic disease that may affect normal healing

• pregnant patients.

• patients with bone diseases and presence of periapical pathology affecting the neighboring teeth.

• Heavy smoker more than 20 cigarettes per day

Related Conditions & MeSH terms

• Implant or Graft; Rejection

Intervention

Other:
• Prf
Take 10 cc blood from patient and gain prf

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Mahmoud adel shaaban

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Primary stability by ostell device	Implant stability will be mesured by ostell device, implant stability will be mesured intra operative at 0 ( time of implant placement ) and 2, 4, 6, 10 and 12 weeks after surgery	up to 3 months